Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland).
Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P.
Cancer Causes Control. 2000 Oct;11(9):847-52.
PMID: 11075874
DOI: 10.1023/A:1008923802001
CONCLUSIONS: We conclude that low levels of 25-VD associated with an increased risk for subsequent earlier exposure and more aggressive development of prostate cancer, especially before the andropause.
Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries.
Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, Stattin P, Harvei S, Hakulinen T, Luostarinen T, Dillner J, Lehtinen M, Hakama M.
Int J Cancer. 2004 Jan 1;108(1):104-8.
PMID: 14618623
DOI: 10.1002/ijc.11375